MDD Augmentation: Low Dose Naltrexone

We finish our lecture series “10 Augmentation Strategies for MDD” with our tenth (and last) lecture on the role of Low Dose Naltrexone as an augmentation for major depressive disorder (MDD).

Understanding the definition of “Low-Dose” in LDN is clinically important. 

Let’s begin by answering this question first:

Q: How is "Low-Dose" Naltrexone (LDN) dose different that Naltrexone dose (NTX) used for opioid use disorder?

Here is one slide from this presentation answering this question:

Role of LDN for MDD augmentation will be discussed in the following sections:

CHAPTER 8: LDN FOR MDD AUGMENTATION

(FOR ACADEMY MEMBERS ONLY)
members only

INTERESTED IN LEARNING MORE?

JOIN ACADEMY’S FIRST LECTURE SERIES OF 2023:

PSYCHIATRY EDUCATION FORUM ACADEMY'S
JANUARY 2023 LECTURE SERIES ANNOUNCEMENT
(JAN 14 - JAN 29, 2023)

MAJOR DEPRESSIVE DISORDER:
10 AUGMENTATION STRATEGIES

Major Depressive Disorder: 10 Augmentation Strategies

JOIN HERE

JOIN ACADEMY MEMBERSHIP:

GENERAL
$ 99/YR
  •  
STUDENTS
$ 75/YR
  •  

DISCOUNTS AVAILABLE FOR: Residents & Students ONLY.

Email us your student information (program information and way to confirm your student status) to: HSingh@PsychiatryEducationForum.com

Related Articles